GLP-1 खर्च भारत (2026): रुग्ण प्रत्यक्ष किती देतात
लागत अक्सर भारतीय परिवारों का निर्णायक कारक। शहर, फार्मेसी, अणु, generic semaglutide से कीमत अलग। 2026 realistic खर्च—insurer ignored hidden costs, titration budgeting—CDSCO-challenged online deals नाही. Sustainable: पहली प्रिस्क्रिप्शन से पहले मासिक ×24 गुणा करें।
Short answer
GLP-1 RA भारतात ₹8,000–₹25,000/माह जेब से—अणु, खुराक, innovator/generic, शहर। Obesity पर insurance कम। RSSDI T2D समर्थन, reimbursement सीमित। Labs, consultation, 12–24 माह बजट। Kesho cost education—औषधे नाही बेचते।
Key takeaways
- •2026 मध्ये अधिकांश GLP-1 ₹8,000–₹25,000/माह जेब से—जब तक employer plan coverage confirm न करे।
- •CDSCO-approved generic semaglutide licensed pharmacy से innovator से 20–40% सस्ता।
- •Titration months lower dose सस्ते—12–24 months minimum budget, सिर्फ first Rx नाही.
- •Hidden: consultations, labs, dietitian, cold-chain travel, sharps—अक्सर ₹2,000–₹5,000 quarterly।
- •Prescription बिना steep online discount CDSCO red flag counterfeit/improper storage।
- •Long-term commit से पहले realistic maintenance monthly ×24 months गुणा करें।
भारतात GLP-1 therapy महँगी क्यों?
GLP-1 RA relatively new, patent/off-patent biologic-class—complex manufacturing, cold-chain, QC। Metformin hundreds/month vs weekly pens sterile production research costs insurance न cover तो consumer। India majority OOP—obesity pharmacotherapy rarely reimbursed, diabetes GLP-1 limited corporate। Context realistic: significant monthly years commitment। Early budget interruption glycaemic rebound/regain। RSSDI T2D clinical value—guideline ≠ insurance payment, Indian patients plan explicitly।
2026 molecule-wise typical price ranges?
Fluctuate, 2025–26 surveys licensed retailers prescription maintenance approximate: Semaglutide injection weekly ₹8,000–₹18,000 dose/product। Oral ₹10,000–₹20,000। Tirzepatide ₹15,000–₹25,000। Liraglutide daily ₹6,000–₹12,000। Dulaglutide semaglutide band। Metro sometimes higher tier-2, online narrowing। Final GST invoice, correct strength/pens/month। Generics semaglutide lower when available।
अनुमानित मासिक GLP-1 लागत (India, 2026)
- औषध वर्ग: Semaglutide injection — मासिक सीमा (INR): ₹8,000 – ₹18,000 — नोट: Dose/product
- औषध वर्ग: Oral semaglutide — मासिक सीमा: ₹10,000 – ₹20,000 — नोट: Daily; strict timing
- औषध वर्ग: Tirzepatide — मासिक सीमा: ₹15,000 – ₹25,000 — नोट: Dual GIP/GLP-1
- औषध वर्ग: Generic semaglutide — मासिक सीमा: ₹6,000 – ₹14,000 — नोट: CDSCO-approved only
- औषध वर्ग: Liraglutide (daily) — मासिक सीमा: ₹6,000 – ₹12,000 — नोट: Older GLP-1 RA
पहले वर्ष GLP-1 budget planner (अनुमान)
- खर्च: Medication only — निम्न (INR/year): ₹72,000 — उच्च: ₹3,00,000
- खर्च: Doctor consultations (quarterly) — निम्न: ₹3,200 — उच्च: ₹10,000
- खर्च: Laboratory tests — निम्न: ₹2,000 — उच्च: ₹8,000
- खर्च: Dietitian/support — निम्न: ₹2,000 — उच्च: ₹12,000
- खर्च: Travel, storage, supplies — निम्न: ₹1,000 — उच्च: ₹5,000
- खर्च: Total first-year — निम्न: ₹80,200 — उच्च: ₹3,35,000
Generic semaglutide भारतात cost कसे बदल रहा?
Patent expiry Indian manufacturers CDSCO generic lower—sometimes 20–40% innovator से। Same bioequivalence/QC। Generic: CLA portal verify, manufacturer reputation, storage। Unverified online extreme low counterfeit red flag। Diabetologist generic prescription; pharmacist substitute consent। Savings vs compromised quality safety risk। ICMR/RSSDI innovator preference नाही both CDSCO-approved same molecule। Itemised receipts month compare।
City/channel से कीमत अलग?
होय, modestly। Mumbai/Delhi premium tier-2 same CDSCO ₹500–₹2,000/month more। Hospital OPD sometimes higher standalone cold-chain confidence। Online licensed promotions injectables temperature delivery packaging confirm। Hyderabad/Chennai/Pune generic competition। Rural travel cold-chain pharmacy। Unlicensed messaging 50–70% discount CDSCO target channels।
Hidden costs patients overlook?
Pen/tablet beyond: endocrinologist ₹800–₹2,500/visit, quarterly HbA1c/lipids ₹500–₹2,000, thyroid/kidney occasional, dietitian ₹500–₹1,500, cold-chain travel। Nausea anti-emetic/meals adjust। Sharps containers। Summer load-shedding fridge backup। Titration lower dose first 2 months slightly less—one pen at a time। Corporate quarterly follow-up leave।
GLP-1 vs other obesity interventions (cost view)
- हस्तक्षेप: GLP-1 pharmacotherapy — Upfront: Low (first Rx) — Monthly: ₹8,000–₹25,000 — Schedule H; CDSCO only
- हस्तक्षेप: Structured lifestyle — Upfront: ₹2,000–₹15,000 — Monthly: ₹500–₹3,000 — ICMR first-line obesity
- हस्तक्षेप: Bariatric surgery — Upfront: ₹2,50,000–₹5,00,000+ — Monthly: Supplements, follow-up — One-time surgical
- हस्तक्षेप: Metformin (off-label weight) — Upfront: Low — Monthly: ₹100–₹500 — Primary obesity drug नाही; diabetes
Medically reviewed
Dr. Ananya Mehta, MD, DM Endocrinology
Consultant Endocrinologist, India
This article has been reviewed by our medical advisory team, including endocrinologists, internal medicine specialists, and cardiologists, and is based on current scientific evidence and Indian clinical guidelines. Last reviewed: June 2026.
Last medically reviewed: Jun 26, 2026